Detection of metachronous neoplasms in colorectal cancer patients: Identification of risk factors

Belen Ballesté, Xavier Bessa, Virginia Piñol, Sergi Castellví-Bel, Antoni Castells, Cristina Alenda, Artemio Paya, Rodrigo Jover, Rosa Ma Xicola, Elisenda Pons, Xavier Llor, Carmen Cordero, Ferran Fernandez-Bañares, Luisa De Castro, Josep Maria Reñé, Montserrat Andreu

Research output: Contribution to journalArticleResearchpeer-review

52 Citations (Scopus)

Abstract

PURPOSE: Patients with colorectal cancer have a high risk of developing metachronous neoplasms. Identification of predictive factors associated with such conditions would allow individualized follow-up strategies in these patients. This study was designed to identify individual and familial factors associated with the development of metachronous colorectal neoplasms in patients with colorectal cancer. METHODS: In the context of a prospective, multicenter, general population-based study-the EPICOLON project-all patients with colorectal cancer attended in ten Spanish hospitals during a one-year period were included. Patients with familial adenomatous polyposis or inflammatory bowel disease were excluded. All patients were monitored by colonoscopy within two years of the diagnoses. Demographic, clinical, pathologic, molecular (microsatellite instability status and immunohistochemistry for MSH2 and MLH1), and familial characteristics (fulfillment of Amsterdam I or II criteria, and revised Bethesda guidelines) were analyzed. RESULTS: A total of 353 patients were included in the study. At two years of follow-up, colonoscopy revealed the presence of adenomas in 89 (25 percent) patients and colorectal cancer in 14 (3.9 percent) patients, in 7 cases restricted to anastomosis. Univariate analysis demonstrated that development of metachronous neoplasm (adenoma or colorectal cancer) was associated with personal history of previous colorectal cancer (odds ratio, 5.58; 95 percent confidence interval, 1.01-31.01), and presence of previous or synchronous adenomas (odds ratio, 1.77; 95 percent confidence interval, 1.21-3.17). Although nonstatistical significance was achieved, metachronisms were associated with gender (P < 0.09) and differentiation degree (P < 0.08). Multivariate analysis identified previous or synchronous adenomas (odds ratio, 1.98; 95 percent confidence interval, 1.16-3.38) as independent predictive factor. Neither presence of tumor DNA microsatellite instability nor family history correlated with the presence of metachronous neoplasms. CONCLUSIONS: Patients with previous or synchronous colorectal adenoma have an increased risk of developing metachronous colorectal neoplasms. Accordingly, this subgroup of patients may benefit from specific surveillance strategies. © 2007 The American Society of Colon and Rectal Surgeons.
Original languageEnglish
Pages (from-to)971-980
JournalDiseases of the Colon and Rectum
Volume50
Issue number7
DOIs
Publication statusPublished - 1 Jul 2007

Keywords

  • Colorectal cancer
  • Metachronous neoplasm
  • Microsatellite instability

Fingerprint Dive into the research topics of 'Detection of metachronous neoplasms in colorectal cancer patients: Identification of risk factors'. Together they form a unique fingerprint.

Cite this